
Medistim ASA
OSE:MEDI

Intrinsic Value
The intrinsic value of one
MEDI
stock under the Base Case scenario is
160.02
NOK.
Compared to the current market price of 174 NOK,
Medistim ASA
is
Overvalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Medistim ASA
Fundamental Analysis


Revenue & Expenses Breakdown
Medistim ASA
Balance Sheet Decomposition
Medistim ASA
Current Assets | 373.2m |
Cash & Short-Term Investments | 127.3m |
Receivables | 85.6m |
Other Current Assets | 160.3m |
Non-Current Assets | 117.8m |
PP&E | 56.3m |
Intangibles | 54.6m |
Other Non-Current Assets | 6.8m |
Free Cash Flow Analysis
Medistim ASA
NOK | |
Free Cash Flow | NOK |
Earnings Waterfall
Medistim ASA
Revenue
|
547.1m
NOK
|
Cost of Revenue
|
-114.2m
NOK
|
Gross Profit
|
432.9m
NOK
|
Operating Expenses
|
-305.4m
NOK
|
Operating Income
|
127.5m
NOK
|
Other Expenses
|
-25.9m
NOK
|
Net Income
|
101.6m
NOK
|
MEDI Profitability Score
Profitability Due Diligence
Medistim ASA's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Score
Medistim ASA's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
MEDI Solvency Score
Solvency Due Diligence
Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDI Price Targets Summary
Medistim ASA
According to Wall Street analysts, the average 1-year price target for
MEDI
is 175.44 NOK
with a low forecast of 173.72 NOK and a high forecast of 180.6 NOK.
Dividends
Current shareholder yield for MEDI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MEDI
stock under the Base Case scenario is
160.02
NOK.
Compared to the current market price of 174 NOK,
Medistim ASA
is
Overvalued by 8%.